GDUFA Negotiations Shift To 'Tiered' Fee Models
Executive Summary
Finance subgroup talks about new structure for generic drug user fee program that could mean bigger firms would pay more.
You may also be interested in...
GDUFA II: ANDAs, Not Facilities Will Govern Revenue
Since applications comprise most of the workload, they will be the focus in the next generic drug user fee cycle.
GDUFA II Will Include Small Business Relief, Priority ANDA Reviews
Generics industry and FDA have resolved remaining issues regarding financing of user fee program.
User Fees For FY 2017 Make Sponsors Happy, Manufacturers Sad
Several facility fees will increase next year as application fees drop.